United Kingdom

People: Agile Therapeutics Inc (AGRX.OQ)

AGRX.OQ on NASDAQ Stock Exchange Capital Market

23 Aug 2019
Change (% chg)

$-0.05 (-4.46%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Coiante, Scott 

Mr. Scott M. Coiante is Senior Vice President of Agile Therapeutics, Inc. He is no longer Chief Financial Officer of the Company, effective August 5, 2019. Beginning in 2005, Beginning in 2005, he served as Vice President Finance, Treasurer, Principal Accounting Officer at Medarex, Inc., a publicly listed biopharmaceutical company, which Bristol-Myers Squibb Co., acquired in September 2009 and during 2002 through 2005, he served as Director of Finance. While at Medarex, he was responsible for corporate financial functions including treasury, accounting, SEC reporting, tax and assurance. From 1989 to 2002, he held management positions of increasing responsibilities at Ernst & Young LLP, which included managing audit engagements, financial preparation, and financial reporting for client public offerings, both initial and follow-on, and SEC registration filing statements for both public and private companies, predominantly within the life science and pharmaceutical industries.

Basic Compensation

Total Annual Compensation, USD 319,833
Restricted Stock Award, USD 79,100
Long-Term Incentive Plans, USD --
All Other, USD 236,956
Fiscal Year Total, USD 635,889

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --